Writing About Experiences and Health in Older Adults II

July 13, 2026 updated by: Naomi Eisenberger, University of California, Los Angeles

UCLA researchers looking for healthy older adults (aged 65+) to participate in a study investigating how writing about experiences can affect your brain and body.

Once a week for 6 weeks, participants will write about their experiences and fill out online questionnaires. Participants will also come to the UCLA campus to complete a neuroimaging session (fMRI), provide a blood spot sample, and fill out questionnaires 2 times: once prior to the 6-week writing period and once immediately after the 6-week writing period.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

200

Phase

  • Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • California
      • Los Angeles, California, United States, 90095
        • Recruiting
        • Center for Cognitive Neuroscience
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Healthy adults age 65 years and older

Exclusion Criteria:

  1. current smokers
  2. active, uncontrolled medical disorders
  3. chronic infection (e.g., Hepatitis C, HIV)
  4. use of certain medications (steroid use, opioid use)
  5. psychiatric disorders (e.g., current major depression, bipolar disorder)
  6. body mass index (BMI) greater than 35
  7. left-handed
  8. claustrophobic
  9. metal in body

Other exclusion criteria may apply.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Writing about Experiences
Participants will be asked to write about experiences with familiar individuals in their lives.
Participants will be asked to write about different kinds of experiences.
Placebo Comparator: Writing about Places
Participants will be asked to write about experiences with familiar places in their lives.
Participants will be asked to write about different kinds of experiences.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Psychological Distress
Time Frame: Baseline, 6 weeks, 10 weeks
Composite measure of depression, anxiety, stress (Beck Depression Inventory, Spielberger Trait Anxiety, and Perceived Stress Scale)
Baseline, 6 weeks, 10 weeks
Change in Social Support
Time Frame: Baseline, 6 weeks, 10 weeks
measure of perceived social support (Social Provisions Scale)
Baseline, 6 weeks, 10 weeks
Change in Social Participation
Time Frame: Baseline, 6 weeks, 10 weeks
measure of participation in social activities (Lifestyle Activities Questionnaire)
Baseline, 6 weeks, 10 weeks
Change in Inflammatory Gene Expression
Time Frame: Baseline, 6 weeks, 10 weeks
changes in proinflammatory gene expression
Baseline, 6 weeks, 10 weeks
Change in Dorsal Anterior Cingulate Cortex (dACC) Activity in response to stress
Time Frame: Baseline, 6 weeks
Parameter estimates from dACC region-of-interest
Baseline, 6 weeks
Change in Anterior Insula Activity in response to stress
Time Frame: Baseline, 6 weeks
Parameter estimates from bilateral anterior insula region-of-interest
Baseline, 6 weeks
Change in Amygdala Activity in response to threat
Time Frame: Baseline, 6 weeks
Parameter estimates from bilateral amygdala region-of-interest
Baseline, 6 weeks
Change in Ventral Striatum Activity in response to prosocial behavior
Time Frame: Baseline, 6 weeks
Parameter estimates from bilateral ventral striatum region-of-interest
Baseline, 6 weeks
Change in Septal Area Activity in response to prosocial behavior
Time Frame: Baseline, 6 weeks
Parameter estimates from septal area region-of-interest
Baseline, 6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Memory
Time Frame: Baseline, 6 weeks, 10 weeks
changes in recall ability (Montreal Cognitive Assessment Test)
Baseline, 6 weeks, 10 weeks
Change in Beliefs about Aging
Time Frame: Baseline, 6 weeks, 10 weeks
changes in cognitive, affective, and social beliefs about aging (Expectations Regarding Aging survey)
Baseline, 6 weeks, 10 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 13, 2023

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Study Registration Dates

First Submitted

August 24, 2022

First Submitted That Met QC Criteria

August 29, 2022

First Posted (Actual)

September 1, 2022

Study Record Updates

Last Update Posted (Actual)

July 14, 2026

Last Update Submitted That Met QC Criteria

July 13, 2026

Last Verified

July 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • R01AG071498 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe